| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,932,900 | 3,670,100 | 4,313,200 | 3,080,800 | | Cost of Revenue | 2,206,400 | 2,801,700 | 3,209,300 | 2,196,200 | | | Gross Profit | 726,500 | 868,400 | 1,103,900 | 884,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 676,600 | 688,200 | 756,500 | 523,000 | | Non Recurring |
-
| 3,710,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 49,900 | (3,529,800) | 347,400 | 361,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,500 | (14,900) | 9,200 | 26,100 | | Earnings Before Interest And Taxes | 62,400 | (3,548,000) | 343,300 | 387,700 | | Interest Expense | 67,400 | 89,000 | 83,300 | 45,600 | | Income Before Tax | (5,000) | (3,637,000) | 260,000 | 342,100 | | Income Tax Expense | 10,500 | (361,800) | 26,400 | 79,600 | | Minority Interest |
-
| (4,100) | (15,900) |
-
| | | | Net Income From Continuing Ops | (15,500) | (3,275,200) | 233,600 | 262,500 | | | Non-recurring Events | | Discontinued Operations | (6,300) | (15,000) | (5,900) | (6,400) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,800) | (3,290,200) | 227,700 | 256,100 | | Preferred Stock And Other Adjustments | (4,900) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($26,700) | ($3,290,200) | $227,700 | $256,100 |
|
0.45% Nasdaq 
0.20%
Income Statement
